Should the NHS be mixing vaccines for better effect, or at least offering people who have had one dose of the AstraZeneca vaccine the choice of having the Pfizer vaccine for their second shot?

The question arises because that is exactly the regime which has been followed in Germany since the risk of clotting from the AstraZeneca vaccine became evident.